New screening strategy aims to catch colorectal cancer early in younger veterans
NCT ID NCT07071454
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study tests whether a multilevel screening program can increase colorectal cancer screening rates among Veterans aged 45-49, an age group now recommended for screening due to rising early-onset cases. Participants are randomly assigned to receive a patient education letter and phone calls, a provider notification, both, or standard care. The goal is to see if these nudges boost screening participation and help prevent colorectal cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this approach could increase early detection and prevention of colorectal cancer in younger Veterans, potentially reducing deaths from the disease.
What could go wrong
The trial is relatively small (536 participants) and focuses on a specific population (Veterans), so results may not apply broadly. The intervention's effectiveness depends on participation and follow-through.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA NY Harbor Healthcare System, New York, NY
New York, New York, 10010-5011, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact